1-[4-hydroxy-5-(methylaminomethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione structure
|
Common Name | 1-[4-hydroxy-5-(methylaminomethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione | ||
|---|---|---|---|---|
| CAS Number | 75191-50-3 | Molecular Weight | 255.27 | |
| Density | 1.311g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C11H17N3O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 1-[4-hydroxy-5-(methylaminomethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione5’-Deoxy-5’-N-methylaminothymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 1-[4-hydroxy-5-(methylaminomethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione |
|---|---|
| Synonym | More Synonyms |
| Description | 5’-Deoxy-5’-N-methylaminothymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.311g/cm3 |
|---|---|
| Molecular Formula | C11H17N3O4 |
| Molecular Weight | 255.27 |
| Exact Mass | 255.12200 |
| PSA | 96.35000 |
| Index of Refraction | 1.555 |
| InChIKey | SMLUVDLCTDSENP-UHFFFAOYSA-N |
| SMILES | CNCC1OC(n2cc(C)c(=O)[nH]c2=O)CC1O |
|
~96%
1-[4-hydroxy-5-... CAS#:75191-50-3 |
| Literature: Elliot; Brockman; Montgomery Journal of Medicinal Chemistry, 1986 , vol. 29, # 6 p. 1052 - 1056 |
|
~%
1-[4-hydroxy-5-... CAS#:75191-50-3 |
| Literature: Idziak, Irene; Just, George; Damha, Masad J.; Giannaris, Paul A. Tetrahedron Letters, 1993 , vol. 34, # 34 p. 5417 - 5420 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| 5'-methylamino-5'-deoxythimidine |